U.S. FDA issues 4 observations to Aurobindo arm’s formulation unit
No impact on the company’s financials
27 Feb 15:18 · The Hindu
U.S. FDA issues four observations to Piramal Pharma’s facility near Hyderabad
Form-483 with four observations
14 Feb 15:14 · The Hindu
last updated on 28 Feb 03:24